IAPP and Cognitive impairment: Taken together, the findings by Adler et al. (2014) and Zhu et al. (2015) emphasize the possibility that blunted (rather than increased) levels of peripheral amylin may underlie the development of neurological and cognitive impairments typically seen in mild cognitive impairment or established AD.